​

Aura Biosciences Ownership | Who Owns Aura Biosciences?

OverviewForecastFinancialsChart

Aura Biosciences Ownership Summary

Aura Biosciences is owned by 87.22% institutional investors, 1.98% insiders, and 10.80% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 11.93% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 8.16% of its assets in Aura Biosciences shares.

AURA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAura Biosciences87.22%1.98%10.80%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Matrix capital management company, lp6.92M11.93%$43.34M
Frazier life sciences management5.10M8.79%$31.93M
Adage capital partners gp4.88M8.41%$30.56M
Long focus capital management4.62M7.96%$28.92M
Suvretta capital management4.37M7.54%$27.37M
Blackrock3.01M6.08%$22.72M
Blackrock funding, inc. /de3.10M5.35%$19.42M
Medicxi ventures management (jersey)3.04M5.24%$19.03M
Vanguard group1.92M3.86%$15.76M
Nantahala capital management2.12M3.65%$13.26M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Matrix capital management company, lp6.92M19.45%$43.34M
Medicxi ventures management (jersey)3.04M4.45%$19.03M
Regency capital management inc.\de665.88K2.19%$4.17M
Samsara biocapital1.00M1.28%$6.26M
Frazier life sciences management5.10M1.28%$31.93M
Long focus capital management4.62M1.09%$28.92M
Levin capital strategies1.50M0.91%$9.36M
Suvretta capital management4.37M0.83%$27.37M
Decheng capital515.55K0.82%$3.23M
Nantahala capital management2.12M0.52%$13.26M

Top Buyers

HolderShares% AssetsChange
Frazier life sciences management5.10M1.28%5.10M
Suvretta capital management4.37M0.83%1.64M
Long focus capital management4.62M1.09%1.30M
Samsara biocapital1.00M1.28%1.00M
Nantahala capital management2.12M0.52%850.00K

Top Sellers

HolderShares% AssetsChange
Eventide asset management---4.08M
Blackrock funding, inc. /de3.10M0.00%-437.42K
Ensign peak advisors---390.69K
Jefferies financial group---222.50K
Verition fund management---151.68K

New Positions

HolderShares% AssetsChangeValue
Frazier life sciences management5.10M1.28%5.10M$31.93M
Samsara biocapital1.00M1.28%1.00M$6.26M
Resolute capital asset partners91.01K0.30%91.01K$569.70K
Susquehanna portfolio strategies56.80K0.01%56.80K$355.56K
Hrt financial lp56.53K0.00%56.53K$353.00K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Ifp advisors-10.00
Capital performance advisors llp-25.00
Us bancorp \de\-27.00
Corecap advisors-33.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20251018.60%50,603,53553.66%872.02%5732.56%29-3.33%
Mar 31, 202594-3.09%39,855,4091.03%791.26%43-27.12%3076.47%
Dec 31, 20249611.63%39,448,5527.00%791.44%5735.71%17-29.17%
Sep 30, 20248613.16%36,866,668-6.95%741.16%41-8.89%2525.00%
Jun 30, 202476-3.80%39,620,9981.29%800.82%45-2.17%2011.11%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I4.08M8.16%-1.72M
Franklin Biotechnology Discv A(acc)USD1.49M2.40%-
Vanguard Total Stock Mkt Idx Inv1.37M2.20%-30.36K
iShares Russell 2000 ETF950.07K1.53%-18.06K
Franklin Biotechnology Discovery A820.94K1.32%-
Fidelity Small Cap Index470.38K0.76%-2.16K
Vanguard Institutional Extnd Mkt Idx Tr427.12K0.69%-194.62K
T. Rowe Price Health Sciences327.62K0.53%-12.34K
iShares Biotechnology ETF284.56K0.46%2.43K
State St Russell Sm/Mid Cp® Indx SL Cl I256.14K0.41%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 18, 2025Elazzouzi Amy Senior Vice President, FinanceSell$51.74K
May 16, 2025Johnson David Michael-Buy$98.00K
May 16, 2025Johnson David Michael-Buy$24.50K
May 16, 2025Gibney Anthony S See RemarksBuy$61.25K
May 16, 2025Gibney Anthony S See RemarksSell$7.82K

Insider Transactions Trends

DateBuySell
2025 Q3-1
2025 Q243
2025 Q1-6
2024 Q4-6
2024 Q3--

AURA Ownership FAQ

Who Owns Aura Biosciences?

Aura Biosciences shareholders are primarily institutional investors at 87.22%, followed by 1.98% insiders and 10.80% retail investors. The average institutional ownership in Aura Biosciences's industry, Biotech Stocks , is 306.59%, which Aura Biosciences falls below.

Who owns the most shares of Aura Biosciences?

Aura Biosciences’s largest shareholders are Matrix capital management company, lp (6.92M shares, 11.93%), Frazier life sciences management (5.1M shares, 8.79%), and Adage capital partners gp (4.88M shares, 8.41%). Together, they hold 29.14% of Aura Biosciences’s total shares outstanding.

Does Blackrock own Aura Biosciences?

Yes, BlackRock owns 6.08% of Aura Biosciences, totaling 3.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 560.52K shares, a 22.93% change.

Who is Aura Biosciences’s biggest shareholder by percentage of total assets invested?

Matrix capital management company, lp is Aura Biosciences’s biggest shareholder by percentage of total assets invested, with 19.45% of its assets in 6.92M Aura Biosciences shares, valued at 43.34M$.

Who is the top mutual fund holder of Aura Biosciences shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Aura Biosciences shares, with 8.16% of its total shares outstanding invested in 4.08M Aura Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools